Ignite Creation Date:
2024-05-05 @ 9:10 PM
Last Modification Date:
2024-10-26 @ 10:00 AM
Study NCT ID:
NCT00824772
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2009-01-16
Brief Title:
Evaluation of Pharmacogenetic Factors Affecting Fentanyl Requirements for Postoperative Pain Control
Sponsor:
Inje University
Organization:
Inje University
Study Overview
Official Title:
Evaluation of Pharmacogenetic Factors Contributing to Dose Requirement of Fentanyl for Postoperative Pain Control Genetic Polymorphisms of OPRM1 ABCB1 CYP3A4 and CYP3A5
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Fentanyl is a widely used opioid analgesic There are big interindividual variabilities in dose requirements of fentanyl for postoperative pain control This study aims to reveal the genetic factors affecting the variable requirements of fentanyl during postoperative period
Detailed Description:
The candidate genes are OPRM1 ABCB1CYP3A4 and CYP3A5
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None